QIAGEN CLC Genomics

CRISPR data analysis and interpretation using QIAGEN Ingenuity Pathway Analysis and CLC Genomics Workbench

1,034 views
May 10, 2022
CRISPR high-throughput sequencing data analysis and pathway interpretation are of great interest to many researchers. Therefore, QIAGEN Digital Insights is hosting this 90-minute training focused on analyzing CRISPR high-throughput sequencing data using QIAGEN CLC Genomics Workbench and interpreting the gene list generated by sequencing data or CRISPR screening using QIAGEN IPA.

Attendees will learn how to use QIAGEN CLC Genomics Workbench to:
• Import sequencing reads (ex. FASTQ format)
• Run reads through a pipeline (e.g., RNA-seq, DNA-seq, etc.)
• Generate and export downstream results (heatmap, differential expression table, genome browser view and more)

Attendees will learn how to use QIAGEN IPA to:
• Study the impact of CRISPR editing on key pathways and regulators
• Compare different CRISPR-modulated biological systems
• Identify a list of regulators and biomarkers specific to conditions of interest
• Export results in the form of high-quality images and tables

Speaker: Araceli Cuellar, Ph.D., Field Application Scientist, QIAGEN Digital insights

Related videos

QIAGEN CLC Genomics

Single-cell RNA-seq: Analysis and interpretation of user and public data - May 20 2021

930 views May 21, 2021

In this 90-minute training, attendees will learn how to analyze and interpret...

QIAGEN CLC Genomics

Workflow construction and customization using QIAGEN CLC Genomics Workbench

54 views February 29, 2024

Recently we have received some requests from CLC users (as well as CLC...

QIAGEN CLC Genomics

Long reads analysis using QIAGEN CLC Genomics workbench (with new features - 2024)

73 views February 20, 2024

This webinar will introduce users to the long read support plugin for Oxford...

QIAGEN CLC Genomics

What’s new in QIAGEN CLC Genomics Workbench version 24

144 views January 31, 2024

QIAGEN CLC Genomics Workbench version 24 is here with exciting updates we'd...